You are here: Industry Insights > COVID-19

News List

Ingenza Achieves COVID-19 Vax Milestone contractpharma
August 20, 2020
Prototype vaccine elicits a powerful immunogenic response in mouse studies.
AIIA and Nisarga Herbs to conduct clinical trial on COVID-19 prevention with Neem capsules expresspharma
August 20, 2020
Nisarga’s neem formulation will be given to 250 front line medical and non-medical staff at ESIC Hospital, Faridabad who are highly exposed to COVID-19 patients.
NPPA rejects IPA request for upward price revision of five per cent on all drugs expresspharma
August 20, 2020
According to DEA analysis concluded that some spike in import prices of certain APIs have been witnessed in the post-COVID-19 period, but it does not validate the claim of IPA for a price increase.
Kimera? Labs Files First FDA Investigational New Drug (IND) Application Using XoGlo? for Treatment of ARDS Secondary to COVID-19 prnewswire
August 19, 2020
Kimera? Labs Inc, a privately held clinical stage biotechnology company, announces the filing of an extended FDA Investigational New Drug (IND) application to study the treatment of COVID-19 related inflammatory disease using Kimera's first-in-class ...
National Safety Council: COVID-19 on Pace to Become Third Leading Cause of Death in 2020 - Surpasses the Total Number of Preventable, Accidental Deaths prnewswire
August 19, 2020
The National Safety Council is highly alarmed to see that the mortality numbers for COVID-19 already have surpassed the total annual number of preventable, accidental deaths in 2018, the most recent year of final data – and it is only August.
Accelerate Diagnostics Announces FDA Emergency Use Authorization for COVID-19 Antibody Testing System prnewswire
August 19, 2020
Accelerate Diagnostics, Inc. and BioCheck, Inc., a privately-held San Francisco-based company focused on in vitro diagnostics, announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the ...
FDA accepts Enzychem’s IND for trial of Covid-19 treatment candidate pharmaceutical-business-review
August 19, 2020
The US Food and Drug Administration (FDA) has accepted Enzychem Lifescience’s investigational new drug application (IND) to assess its EC-18 therapeutic candidate for the prevention of acute respiratory disease syndrome (ARDS) due to Covid-19 pneumonia.
Hancock confirms replacement of Public Health England pharmatimes
August 19, 2020
Health and Care Secretary Matt Hancock has confirmed that Public Health England (PHE) will be replaced with a new organisation called the National Institute for Health Protection (NIHP).
Gov announces expansion of UK's ONS COVID-19 survey pharmatimes
August 19, 2020
Health and Social Care Secretary Matt Hancock has announced plans to expand the Office for National Statistics' (ONS) infection survey to increase insight into the prevalence and spread of COVID-19.
COVID-19 WHO Emergency Committee Highlights Need for Long-Term Response americanpharmaceuticalreview
August 19, 2020
The World Health Organization (WHO) Emergency Committee on COVID-19, convened by the WHO Director-General under the International Health Regulations (2005) (IHR), issued a statement following the committee’s most recent meeting.